COURT-RULING ·Filed Apr 27, 2026

HCA

HCA Healthcare, Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed4mo ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

This venue transfer filing is immaterial — no trade action needed. Monitor for any subsequent substantive rulings in the S.D. Florida docket, but the likelihood of a material judgment against HCA is negligible.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
HCA ▼ -16.56% at T+60d
NEUTRAL call ✗ call lost -16.56% · α vs SPY -21.07% · entry $445.70 → $371.87
Entry anchored
Apr 24, 03:59 PM ET
via exchange tick
T+1d
-3.19%
call -3.19% · α -2.70%
$431.48
settled 5mo ago
T+5d
-4.18%
call -4.18% · α -4.58%
$427.06
settled 5mo ago
T+20d
-11.94%
call -11.94% · α -16.87%
$392.48
settled 4mo ago
T+60d
-16.56%
call -16.56% · α -21.07%
$371.87
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

A pro se plaintiff's EMTALA claim against Wilson Medical Center, HCA Florida Kendall Hospital, and other defendants was transferred from the Southern District of New York to the Southern District of Florida for convenience. This routine venue transfer does not adjudicate any liability and entirely lacks material financial exposure or business impact for HCA Healthcare.

Court Ruling Details

Ruling Date
Apr 27, 2026
Court
United States District Court for the Southern District of New York
Court Level
District
Judge
Laura Taylor Swain
Case Type
other
Ruling Type
procedural
Outcome
WIN — ruling favors this company
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW

Key Facts

  • Case involves EMTALA claim against HCA Florida Kendall Hospital; no liability or damages determined.
  • SDNY transferred the case to the Southern District of Florida under 28 U.S.C. § 1404(a) for convenience.
  • No injunction, damages award, or precedent risk imposed on HCA by this procedural order.
  • Individual pro se plaintiff; exposure is trivial (< 0.001% of HCA's $87B market cap) even if fully adjudicated.

Financial Impact

No damages, settlement, or financial exposure stated in the order; individual EMTALA claim is de minimis for an $87B company.

revenue

Risk Factors

  • No material risk identified from this procedural order.

Market Snapshot

Exchange
NYSE
Sector
Services-General Medical & Surgical Hospitals, NEC
Analyst Consensus
63% bullish (30 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-2gqm9fcl-HCA
8 reports for HCA
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for HCA — sortable, filterable
TypeNow
Jul 24, 2026
10w ago
8-K
MIXED ★ 5/10
$382.19 $429.19▲ +12.30%▲ +8.67%$426.69 (+11.64%)
Jul 14, 2026
11w ago
8-K
BEARISH ★ 6/10
$363.60 $411.44▼ −13.16%▼ −10.67%$426.69 (−17.35%)
Jun 18, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$375.17 $385.74▲ +2.82%▲ +2.28%$426.69 (+13.73%)
Apr 27, 2026
22w ago
8-K
NEUTRAL ★ 3/10
$431.48 $392.42▼ −9.05%▼ −14.52%$426.69 (−1.11%)
Apr 27, 2026
22w ago
Court Ruling
NEUTRAL ★ 1/10
$445.70 $392.48▼ −11.94%▼ −16.87%$426.69 (−4.26%)
Apr 24, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$432.55 $392.56▼ −9.25%▼ −13.27%$426.69 (−1.36%)
Mar 13, 2026
29w ago
DEFA14A
NEUTRAL ★ 3/10
$525.04 $496.74▼ −5.39%▼ −9.17%$426.69 (−18.73%)
Feb 25, 2026
31w ago
8-K
NEUTRAL ★ 3/10
$525.78 $479.78▼ −8.75%▼ −2.35%$426.69 (−18.85%)
Showing 8 of 8

US Market Status

Market Closed — Opens Mon (38h 30m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access